Precision

Cumulative exposures, focus on precision medicine from the Mayo conference (Environmental Factor, December 2022)

Cumulative exposures, focus on precision medicine from the Mayo conference (Environmental Factor, December 2022)

“Explore the Exposome: The Next Frontier in Individualizing Medicine” was the title of a Mayo Clinic conference that brought together experts from around the world, including NIEHS leaders and grantees, November 2 and 3 in Rochester, Minnesota. Participants explored how the exposome – the totality of a person’s lifetime exposures and their corresponding biological effects …

Cumulative exposures, focus on precision medicine from the Mayo conference (Environmental Factor, December 2022) Read More »

Global NGS Kits Market Report 2022 to 2032: Growing Application of NGS Kits in Precision Medicine and Molecular Diagnostics Presents Opportunities

Global NGS Kits Market Report 2022 to 2032: Growing Application of NGS Kits in Precision Medicine and Molecular Diagnostics Presents Opportunities

company logo Global NGS Kit Market Global NGS Kit Market Dublin, 01 Dec. 2022 (GLOBE NEWSWIRE) — The “NGS Kits Market – A Global and Regional Analysis: Focus on Workflow, Sequencing Type, Usage, Application, End User and Region – Analysis and forecast, 2022-2032” report has been added to from ResearchAndMarkets.com offer. In 2021, the Global …

Global NGS Kits Market Report 2022 to 2032: Growing Application of NGS Kits in Precision Medicine and Molecular Diagnostics Presents Opportunities Read More »

Precision medicine is the answer for this problem-solving lung cancer survivor

Precision medicine is the answer for this problem-solving lung cancer survivor

John Ryan knows how science can be applied to solve problems. An information systems engineer, he works from home to manage projects and write recommendations. After a busy day innovating in technology, he devotes his energy to promoting the adoption of cats. “Cats are a bit complicated, maybe that’s why I like taking care of …

Precision medicine is the answer for this problem-solving lung cancer survivor Read More »

Global Pharmacogenomics Markets, Analysis and Forecast, 2016-2021, 2021-2026F, 2031F: Focus on Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarrays DNA

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth

Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) — The report “Europe Precision Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End User” has been added to from ResearchAndMarkets.com offer. Europe Precision Diagnostics Market is expected to grow from US$23,317.64 million in 2022 to US$48,500.85 million by 2028. It …

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth Read More »

Cancer research

Opening of a precision medicine trial for rare cancers in adults and children

Its unique design means that any treatment that appears to work for patients in the trial will be submitted for review to the Cancer Drug Fund (CDF)**** who will then decide whether to collect more data and assess whether the drug could be used as a routine treatment option on the NHS for patients with …

Opening of a precision medicine trial for rare cancers in adults and children Read More »

Texas A&M AgriLife Launches Automated Precision Phenotyping Greenhouse

Texas A&M AgriLife Launches Automated Precision Phenotyping Greenhouse

Equipped with state-of-the-art robotics, remote sensing and data capture capabilities, Texas A&M AgriLife Research has launched “the future of agricultural research” with its multimillion-dollar automated precision phenotyping greenhouse on the campus of Texas A&M University at Bryan-College Station. The greenhouse is part of the Texas A&M AgriLife PLant Growth and phenotyping facilitywhich also includes the …

Texas A&M AgriLife Launches Automated Precision Phenotyping Greenhouse Read More »

Ionis (IONS) enters into an agreement to develop precision genetic drugs

Ionis (IONS) enters into an agreement to develop precision genetic drugs

Ionis Pharmaceuticals, Inc. IONS announced that it has entered into a collaboration with a private California-based gene editing company, Metagenomi, to add gene editing to its extensive technology platform. With this partnership, the companies seek to leverage Ionis’ expertise in RNA-targeted therapies with Metagenomi’s next-generation gene editing systems to develop novel gene targets. Initially, the …

Ionis (IONS) enters into an agreement to develop precision genetic drugs Read More »